Results 291 to 300 of about 469,546 (342)

Safety of magnesium orotate dihydrate as a novel food pursuant to Regulation (EU) 2015/2283 and bioavailability of magnesium from this source in the context of Directive 2002/46/EC. [PDF]

EFSA J
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, Cámara Hurtado MM, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Jos Á, Maciuk A, Mangelsdorf I, Mcnulty B, Naska A, Pentieva K, Siani A, Thies F, Cubadda F, Frenzel T, Gundert-Remy U, Marcon F, Prieto Maradona M, Neuhäuser-Berthold M, Siskos A, Wright M, Matijević L, McArdle H.   +25 more
europepmc   +1 more source

Pharmacokinetic variability of 20(S)-protopanaxadiol-type ginsenosides Rb1, rd, and compound K from Korean red ginseng in experimental rodents. [PDF]

Sci Rep
Jeong JS, Kim JW, Kim JH, Kim CY, Chung EH, Boo SY, Giorgi M, Ko JW, Kim TW.   +8 more
europepmc   +1 more source

Enhancing Bioavailability of Water-Soluble Drugs through Precision Electrostatic Spraying.

J Pharm Bioallied Sci
Barole ND, Thitame SN, Aher A, Rajurkar VD.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Absorption, metabolism and bioavailability of flavonoids: a review

Critical reviews in food science and nutrition, 2021
Flavonoids are stored in various plants and widely presented in different kinds of food in variable amounts. Plant roots, stems, leaves, flowers and fruits are known to have high amounts of flavonoids.
Lei Chen, H. Cao, Qun Huang, Jianbo Xiao, Hui Teng   +4 more
semanticscholar   +1 more source

Molecular properties that influence the oral bioavailability of drug candidates.

Journal of Medicinal Chemistry, 2002
Oral bioavailability measurements in rats for over 1100 drug candidates studied at SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline) have allowed us to analyze the relative importance of molecular properties considered to influence that drug ...
D. Veber, Stephen R. Johnson, Hung‐Yuan Cheng, B. Smith, K. Ward, K. Kopple   +5 more
semanticscholar   +1 more source

Bioavailability of Digoxin

New England Journal of Medicine, 1971
A variable or poor response to a therapeutic agent may not have its origin in the patient; it may be due to a formulation defect in the drug product administered. The most commonly recognized formulation defect in a dosage form such as a tablet is a deficiency or excess of the active ingredient.
Trieste G. Vitti, Theodore E. Byers, Daniel Banes   +2 more
openaire   +3 more sources

Bioavailability of curcumin: problems and promises.

Molecular Pharmaceutics, 2007
Curcumin, a polyphenolic compound derived from dietary spice turmeric, possesses diverse pharmacologic effects including anti-inflammatory, antioxidant, antiproliferative and antiangiogenic activities.
P. Anand, A. Kunnumakkara, R. Newman, B. Aggarwal   +3 more
semanticscholar   +1 more source

A Bioavailability Score [PDF]

Journal of Medicinal Chemistry, 2005
Responding to a demonstrated need for scientists to forecast the permeability and bioavailability (F) properties of compounds before their purchase, synthesis, or advanced testing, we have developed a score that assigns the probability that a compound will have F > 10% in the rat.
openaire   +2 more sources

Bioavailability of tolamolol

European Journal of Clinical Pharmacology, 1976
Bioavailability of capsule and tablet formulations of tolamolol were compared by measuring plasma concentration of tolamolol and reduction in maximum exercise heart rate over a period of twelve hours in eight healthy subjects in a two-way cross-over study.
D. A. Stopher, S. H. Taylor, J. K. Faulkner, W. Singleton, R. Walden   +4 more
openaire   +3 more sources